Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2003
04/09/2003CN1408880A Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use
04/09/2003CN1408850A Immortal technology for human blood dentritic cell
04/09/2003CN1408437A Microcapsule adrenomedullary cell for curing malignant, tumor pain and its preparing method
04/09/2003CN1105187C Protocadherin proteins and their use
04/09/2003CN1105184C Enzyme with protease activity
04/08/2003US6545202 Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene
04/08/2003US6545199 Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine
04/08/2003US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/08/2003US6544965 Compounds with an antioxidant activity, compositions useful as food integrators containing them and process for their preparation
04/08/2003US6544955 Method of sensitizing tumor cells with adenovirus E1A
04/08/2003US6544790 Inserting Dna into cells
04/08/2003US6544787 Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation
04/08/2003US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon
04/08/2003US6544767 Genetic engineering; isolated polypeptide
04/08/2003US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer
04/08/2003US6544760 Kunitz domain polypeptide Zkun11
04/08/2003US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine
04/08/2003US6544758 Methods for expressing endostatin protein
04/08/2003US6544753 Dietetics; analgesics; cognition activators; detecting binding
04/08/2003US6544751 Methods of harvesting rare cells from blood products
04/08/2003US6544748 Preparation of erythropoietin by endogenous gene activation
04/08/2003US6544733 Method of identifying non-host plant disease resistance genes
04/08/2003US6544514 Compositions comprising, as the main ingredient, allogenic activated-C4+ cells and method for producing and using the same
04/08/2003US6544506 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
04/08/2003US6544505 Interferon-epsilon
04/08/2003US6544166 Treatment of human infertility
04/08/2003CA2228046C Root cortex specific gene promoter
04/08/2003CA2184584C Vascular endothelial growth factor 2
04/08/2003CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them
04/08/2003CA2107732C Retrovirus from the hiv group and its use
04/08/2003CA2008368C Soluble molecule related to but distinct from icam-1
04/08/2003CA2006332C Method of detecting neurological disease or dysfunction
04/04/2003CA2406610A1 Embryonic stem cells and neural progenitor cells derived therefrom
04/03/2003WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
04/03/2003WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/03/2003WO2003027588A1 A method for use of latent heat to maintain selectable cold storage temperatures
04/03/2003WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
04/03/2003WO2003027316A2 Methods of using 33751, a human potassium channel family member
04/03/2003WO2003027306A2 Bgl3 beta-glucosidase and nucleic acids encoding the same
04/03/2003WO2003027300A2 Use of aminoglycoside resistance gene
04/03/2003WO2003027294A1 Glucose dehydrogenase
04/03/2003WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027287A1 Kidney-specific urate transporter and gene thereof
04/03/2003WO2003027285A1 Dna sequences for human angiogenesis genes
04/03/2003WO2003027282A1 Adamts-15, -16, -17, -18 and -19
04/03/2003WO2003027281A2 Pluripotent stem cells originating in skeletal muscle intestinal tissue
04/03/2003WO2003027278A1 Tailor-made multifunctional stem cells and utilization thereof
04/03/2003WO2003027277A1 Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
04/03/2003WO2003027271A2 Regulation of adenovirus dna packaging by iptg
04/03/2003WO2003027270A1 Growing xenotransplant material in culture
04/03/2003WO2003027269A1 Chronic pathogen-expressing cell lines
04/03/2003WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027264A2 Coisogenic eukaryotic cell collections
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027256A2 Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic t lymphocyte activity
04/03/2003WO2003027254A2 15625 receptor, a novel g-protein coupled receptor
04/03/2003WO2003027253A2 Variants of alpha-fetoprotein coding and expression sequences
04/03/2003WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
04/03/2003WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof
04/03/2003WO2003027247A2 Modulation of stem cells using zinc finger proteins
04/03/2003WO2003027246A2 Antagonists
04/03/2003WO2003027245A2 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
04/03/2003WO2003027244A2 Antisense oligonucleotides and methods to induce tumor cell death
04/03/2003WO2003027242A2 Fas ligand
04/03/2003WO2003027240A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor
04/03/2003WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027224A1 Optoinjection methods
04/03/2003WO2003027150A1 Antibody and use thereof
04/03/2003WO2003027147A2 Human coagulation factor vii polypeptides
04/03/2003WO2003027146A1 Use of cardiotrophin in hepatic diseases
04/03/2003WO2003027143A2 Gene and protein relating to hepatocellular carcinoma
04/03/2003WO2003027141A1 Plant polypeptides and polynucleotides encoding same
04/03/2003WO2003026712A1 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same
04/03/2003WO2003026696A1 Method of controlling proliferation of cancer cells and cell death
04/03/2003WO2003026691A2 Use of hmgb1 for the activation of dendritic cells
04/03/2003WO2003026689A1 Autologous growth factor cocktail composition, method of production and use
04/03/2003WO2003026670A2 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags)
04/03/2003WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003WO2003026580A2 Interactive therapeutic enclosures
04/03/2003WO2003026578A2 Pine cone extracts and uses thereof
04/03/2003WO2003026566A2 Atlastin
04/03/2003WO2003026479A2 Methods of suppressing microglial activation
04/03/2003WO2003026409A2 Kv1.7 potassium channel disruptions, compositions and methods relating thereto
04/03/2003WO2003026407A1 Glycerol kinase gene disruptions, compositions and methods related thereto
04/03/2003WO2003026404A2 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026401A2 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
04/03/2003WO2003026398A2 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026397A2 Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026396A2 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
04/03/2003WO2003026395A2 Mo54 gene disruptions, compositions and methods related thereto
04/03/2003WO2003012084A3 Human glucose-dependent insulin-secreting cell line
04/03/2003WO2003006104A3 Lymphatic endothelial cells materials and methods
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2002099052A3 Opns as modifiers of the p53 pathway and methods of use
04/03/2003WO2002099051A3 Nits as modifiers of the p53 pathway and methods of use
04/03/2003WO2002088338A3 Method for replicating the hepatitis c virus
04/03/2003WO2002088336A3 Genetically modified yt cell line and use thereof
04/03/2003WO2002085297A3 Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
04/03/2003WO2002085286A8 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals
1 ... 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 ... 1827